PharmAust (ASX: $PAA) trading halt request details

PharmAust Limited (ASX: $PAA) has requested a trading halt for its ordinary shares and listed options on the Australian Securities Exchange (ASX) in accordance with ASX Listing Rule 17.1. The trading halt is pending an announcement by the company regarding a capital raising. The company expects to make the announcement before the commencement of normal trading on Friday, 21 June 2024.

PharmAust (ASX: $PAA) company secretary's statement on trading halt request

The trading halt has been requested to manage the continuous disclosure obligations of PharmAust Limited as the company prepares to make an announcement regarding a capital raising. The company secretary, Stefan Ross, has stated that the trading halt is expected to be in place until the announcement is released to the market before the commencement of normal trading on Friday, 21 June 2024.

PharmAust (ASX: $PAA) trading halt summary and outlook

PharmAust Limited (ASX: $PAA) has requested a trading halt in preparation for an announcement related to a capital raising. The company aims to manage its continuous disclosure obligations and expects to release the announcement before the commencement of normal trading on Friday, 21 June 2024. This move indicates the company's proactive approach to maintaining transparency and fulfilling its disclosure requirements. The market will be keen to assess the details of the capital raising and its potential impact on PharmAust's corporate strategy and future prospects.